About
Technology
Issues
FAQ
Links
Official Page
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for
Helicobacter pylori
eradication: a phase III, randomised, double-blind study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.